ImmunXperts, a Q² Solutions Company ImmunXperts, a Q² Solutions Company

Menu
  • Home
  • Services
    • Immunogenicity
    • Immuno-Oncology
    • Cell Therapy
    • ImmunAcademy
  • About Us
    • Team
    • Scientific Advisory Board
  • News & Events
  • Contact Us
  • Careers

You are here:

  1. Home
  2. News & Events
  3. Immuno-Oncology 2018

Immuno-Oncology 2018

14 August 2018

ImmunXperts’ Jana Schockaert will be giving a presentation on “Unwanted Immunogenicity and Functionality Testing of Immuno-Oncology Drugs” at SMi’s Immuno-Oncology Conference held in London on September 26-27, 2018.

http://smi-online.co.uk/pharmaceuticals/uk/conference/cancer-vaccines

 

Posted in:
  • Events

See more

  1. Prev:Antibody Engineering and Immuno-Oncology Xchange 2018
  2. Back: All Posts
  3. Next:BEBPA EUR Bioassay Conference

Recent Posts

  • In vitro Immunogenicity and Functional Testing of Nanoparticles, mRNA, and Biologics
  • Happy to join the Nexelis family
  • 11th Open Scientific EIP Symposium on Immunogenicity of Biopharmaceuticals
  • Innovation for Health
  • PEGS Europe, 18-22 November 2019, Lisbon

Categories

  • Events
  • News
  • Uncategorized
 
  • linkedin
  • twitter

Services

  • Immunogenicity
  • Immuno-Oncology
  • Cell Therapy
  • ImmunAcademy

About Us

  • Team
  • Scientific Advisory Board

News & Events

  • News
  • Events
Website by Uchrony
  • Home
  • Contact Us
  • Careers

© ImmunXperts, a Q² Solutions Company | Rue Auguste Piccard 48 6041 Gosselies | +32(0)71960133


Contact Us
Q² Solutions, a wholly owned subsidiary and laboratory division of IQVIA, is a leading global clinical trial laboratory services organization providing comprehensive testing, project management, supply chain, biorepository and specimen management, and clinical trial sample and consent tracking solutions.
Learn more at www.q2labsolutions.com.

Back to Top